BeStock  
Stocks › Biotechnology › VCEL

Vericel VCEL

US equityMarket cap rank #2449BiotechnologyCAR-T Therapy
$57.52 −$0.74 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $57.52 0.00%
Open$58.11
Prev close$58.26
Day range$57.33 – $59.49
Volume582.3K
Market cap$2.94B
P/E (TTM)89.9
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership109.6%-1.47 pts vs. prior quarter
Institutions holding389+3 vs. prior quarter
Insider trades (recent)19 buys / 31 sellsNet selling
Short interest10.48% of floatDays to cover 9.8 · as of 30 Oct 2026
Short-sale volume share14.6%5-day average of daily volume

Short-sale volume as % of daily volume

8%15%23%30%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.78M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$2.1MSuper+$316.5KBig−$2.1MMid−$4.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.6% of shares outstanding.

Largest holders

  • BlackRock16.00%
  • State Street Global Advisors6.28%
  • Congress Asset Management Company, LLP5.00%
  • Vanguard Capital Management, LLC4.43%
  • William Blair Investment Management, LLC3.84%
  • BNPP Asset Management Holding3.21%
  • Conestoga Capital Advisors, LLC3.08%
  • GW&K Investment Management, LLC3.01%

By investor type

  • Mutual Fund90.70%
  • Hedge Fund10.12%
  • Public Company4.54%
  • Government Pension Fund1.71%
  • Insurance Company1.33%
  • Individual/Insider1.20%
  • Private Company0.82%
  • Sovereign Wealth Fund0.19%

Reported short interest has risen from 9.22% to 10.48% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +148,141 1.1%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +136,785 0.6%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +136,288 0.4%
Winton Capital Group Limited Hedge Fund 2026/Q3 +98,136 0.3%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +96,379 0.7%
FMR Mutual Fund 2026/Q3 +93,286 0.3%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +85,751 0.7%
BlackRock Mutual Fund 2026/Q3 +75,079 16.0%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +65,293 0.5%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +61,840 1.9%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +481,684 1.0%
Congress Asset Management Company, LLP Mutual Fund 2026/Q3 +1,409,377 5.7%
Next Century Growth Investors LLC Mutual Fund 2026/Q3 +459,805 1.2%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +392,196 1.0%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +336,547 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
12 Nov 2026 Jonathan Siegal Principal Accounting Officer, VP & Corporate Controller Intent to Sell (Form 144) -1,885 $57.71 –
10 Nov 2026 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -8 $59.75 –
10 Nov 2026 Joseph Mara Chief Financial Officer Derivative Exercise and Sale -25,008 $59.75 16,186
10 Nov 2026 Joseph Mara Chief Financial Officer Other Derivative Acquisition +25,008 $43.63 134,992
9 Nov 2026 Kevin McLaughlin Independent Director Derivative Exercise and Sale -7,000 $58.96 18,300
9 Nov 2026 Kevin McLaughlin Independent Director Other Derivative Acquisition +7,000 $13.05 –
8 Nov 2026 Robert Zerbe Independent Chairperson Derivative Exercise and Sale -2,000 $57.88 32,995
8 Nov 2026 Robert Zerbe Independent Chairperson Other Derivative Acquisition +2,000 $13.05 –
8 Nov 2026 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -25,000 $58.26 –
5 Nov 2026 Joseph Mara Chief Financial Officer Intent to Sell (Form 144) -28,641 $53.42 –
5 Nov 2026 Joseph Mara Chief Financial Officer Derivative Exercise and Sale -28,641 $53.43 16,186
5 Nov 2026 Joseph Mara Chief Financial Officer Other Derivative Acquisition +50,000 $34.90 21,250
4 Nov 2026 Robert Zerbe Independent Chairperson Intent to Sell (Form 144) -3,000 $52.23 –
4 Nov 2026 Sean Flynn Chief Legal Officer Derivative Exercise and Sale -15,000 $51.92 1,990
4 Nov 2026 Joseph Mara Chief Financial Officer Other Acquisition +21,359 $34.90 16,186
4 Nov 2026 Joseph Mara Chief Financial Officer Open Market Disposition -21,359 $53.73 16,186
4 Nov 2026 Jonathan Siegal Principal Accounting Officer, VP & Corporate Controller Derivative Exercise and Sale -1,500 $52.90 1,259
4 Nov 2026 Robert Zerbe Independent Chairperson Derivative Exercise and Sale -5,500 $55.00 32,995
3 Nov 2026 Robert Zerbe Independent Chairperson Intent to Sell (Form 144) -2,500 $45.40 –
11 Aug 2026 Kevin McLaughlin Independent Director Derivative Exercise and Sale -7,000 $44.53 18,300

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,364,126 10.5% 9.8
15 Oct 2026 5,238,041 10.2% 9.5
30 Sep 2026 5,202,417 10.2% 9.6
15 Sep 2026 5,483,102 10.7% 12.1
31 Aug 2026 4,759,226 9.3% 9.0
14 Aug 2026 4,723,479 9.2% 11.5

Discussion

No comments yet — be the first to weigh in on VCEL.

Sign in to join the discussion.

Scroll to Top